dna13 Inc.

dna13 Inc. specializes in the sale of premium domain names, focusing on online real estate for entrepreneurs, small business owners, and personal brands seeking to enhance their online presence. Founded in 2001 in New York, US, dna13 Inc. operates within the domain name market.

In April 2010, the company was acquired by CNW Group Ltd. The firm has completed a total of 3 deals, with the latest funding round being a Series B, which raised USD 2. 80 mn from Celtic House Venture Partners and Propulsion Ventures. The company's primary offering is the sale of premium domain names, with a focus on the online real estate market.

Their core product, exemplified by the domain dna13. com, is priced at USD 595, with an option for customers to pay through a monthly installment plan of USD 49. 58 over a 12-month period. This service targets various end-users, including entrepreneurs, small business owners, and individuals looking to establish a personal brand online.

The company caters to a global market, enabling clients from diverse geographical regions to acquire domain names that are vital for their online presence. Key functionalities include domain transfer services, SSL encryption for secure transactions, and optional privacy protection for domain ownership information, which further enhances the user experience and addresses the need for security in online transactions. The company generates revenue through the direct sale of domain names and associated services. Transactions occur primarily on a B2C basis, where individuals or businesses purchase domain names directly from the company.

The pricing structure is straightforward; clients pay a one-time fee or opt for a monthly payment plan to acquire their desired domain. Alongside the sale of domain names, additional revenue is derived from optional services such as WhoIs Privacy Protection and email hosting packages offered through their registrar, NameBright. com. By providing a seamless purchasing experience, the company facilitates quick domain access, usually within a few hours of transaction completion, thereby enhancing customer satisfaction and loyalty.

As of now, dna13 Inc. has not publicly outlined specific new products in development or targeted upcoming markets for expansion. The recent funding from the Series B round raised USD 2. 80 mn will likely support operational growth and could enhance their domain offerings and service capabilities.